The global Bipolar Disorder Drugs And Treatment Market is anticipated to expand at a stable CAGR of 2.72% throughout the forecast US$ 4.4 Billion by the end of the year 2023 to reach a valuation of US$ 5.8 Billion by the year 2033. According to a recent study by Future Market Insights, anti-psychotic drugs are leading the market with an expected share of about 40.2% in the year 2023, within the...